177 related articles for article (PubMed ID: 17145821)
21. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
[TBL] [Abstract][Full Text] [Related]
23. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
Ku JH; Choi WS; Kwak C; Kim HH
Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
[TBL] [Abstract][Full Text] [Related]
24. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
[TBL] [Abstract][Full Text] [Related]
25. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
Kusuda Y; Miyake H; Terakawa T; Kondo Y; Miura T; Fujisawa M
Urol Oncol; 2013 Aug; 31(6):899-903. PubMed ID: 21824792
[TBL] [Abstract][Full Text] [Related]
26. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
[TBL] [Abstract][Full Text] [Related]
27. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Bumbasirevic U; Vukovic I; Dragicevic D; Tulic C
BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
[TBL] [Abstract][Full Text] [Related]
28. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
29. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
Liu Y; Lu J; Hong K; Huang Y; Ma L
Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
[TBL] [Abstract][Full Text] [Related]
30. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
31. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
32. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
[TBL] [Abstract][Full Text] [Related]
34. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
[TBL] [Abstract][Full Text] [Related]
35. [Endo-urologic surgery of urothelial tumors of the upper urinary tract].
Martínez-Piñeiro JA; Hidalgo Togores L; Martínez-Piñeiro L; Cózar Olmo JM; Moreno JA
Arch Esp Urol; 1991 Jun; 44(5):529-39. PubMed ID: 1722082
[TBL] [Abstract][Full Text] [Related]
36. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
38. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
39. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
40. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
